REFERENCES
- Klingmüller D, Saller B, Quabbe H. Diagnostik von Hypophysenadenomen. Dtsch Aerztebl 2001;98(46): A-3053/B-2595/C-2403.
- Schteingart DE. Drugs in the medical treatment of Cushing’s syndrome. Expert Opin Emerg Drugs 2009;14:661–671.
- Chanson P, Salenave S, Kamenicky P, Cazabat L, Young J. Pituitary tumours. acromegaly. Best Pract Res Clin Endocrinol Metab 2009;23:555–574.
- Losa M, Fortunato M, Molteni L, Peretti E, Mortini P. Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy. Minerva Endocrinol 2008;33:329–340.
- Zatelli MC, Ambrosio MR, Bondanelli M, Uberti EC. Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds. Eur J Endocrinol 2007;156 (Suppl 1):S29–S35.
- Caprioli J. Automated perimetry in glaucoma. Am J Ophthalmol 1991;111:235–239.
- Bundesministerium für Verkehr, Bau und Stadtentwicklung; types of driving licences in Germany. Available at: www.bmvbs.de.
- Fahreignungsbegutachtung fuer den Strassenverkehr 2008. Empfehlung der Deutschen Ophthalmologischen Gesellschaft (DOG) und des Berufsverbands der Augenaerzte Deutschlands (BVA), edited by and available at DOG and BVA.
- Schiefer U, Hofer R, Vischer PM, Wilhelm H. Perimetry findings and driving performance. “How much visual field” does a motorist need? Ophthalmologe 2000;97:491–497.
- Riddoch G. Dissociation of visual perception due to occipital injuries, with especial reference to appreciation of movement. Brain 1917;40:15–57.
- Zappia RJ, Enoch JM, Stamper R, Winkelman JZ, Gay AJ. The Riddoch phenomenon revealed in non-occipital lobe lesions. Br J Ophthalmol 1971;55:416–420.
- Safran AB, Glaser JS. Statokinetic dissociation in lesions of the anterior visual pathways. A reappraisal of the Riddoch phenomenon. Arch Ophthalmol 1980;98:291–295.
- Hudson C, Wild JM. Assessment of physiologic statokinetic dissociation by automated perimetry. Invest Ophthalmol Vis Sci 1992;33:3162–3168.